Physician

Paul M Katz, DO

According to 2025 Medicare claims, Paul Katz, DO (NPI: 1629047154) practices family practice in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from Cecil, MD. This provider's primary affiliated billing organization is CHESAPEAKE WELLNESS CENTER (NPI: 1083163307; TIN: 813972377) and primary practice location at 21913-2191. Katz is affiliated with the Netrin Primary Care ACO, LLC (ACO ID: A3272), participating under the MSSP model.

Katz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 192 traditional Medicare patients, billed 1,618 HCPCS/CPT codes, and received $80,253 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 2,105 prescription claims across 175 beneficiaries totaling $201,801 in drug costs, led by Jardiance (Empagliflozin). 2022 DME data shows 58 claims. Open Payments data shows 6 records totaling $122. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $93,356 and ending at $80,253. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $300,796 and ending at $201,801. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,784 and ending at $2,850.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	125	1,804	$93,356
2016	284	2,821	$152,616
2017	259	2,797	$142,210
2018	218	1,611	$71,621
2019	196	1,282	$64,448
2020	190	1,766	$86,853
2021	216	2,363	$132,196
2022	223	2,294	$109,869
2023	210	2,050	$89,634
2024	192	1,618	$80,253

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	108	2,788	$300,796
2016	217	3,720	$371,714
2017	222	3,761	$365,514
2018	214	3,328	$389,551
2019	173	2,076	$236,340
2020	142	2,220	$268,782
2021	184	2,575	$334,960
2022	221	2,766	$321,550
2023	202	2,476	$342,712
2024	175	2,105	$201,801

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	29	176	$4,210
2016	53	129	$2,242
2017	38	112	$5,532
2018	40	126	$2,884
2019	32	70	$1,121
2020	12	64	$3,951
2021	11	78	$7,766
2022	N/R	58	$4,041
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	132	132	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	184	667	$58
G0008	Administration of influenza virus vaccine	53	54	$31
90658	Influenza vaccine, trivalent, 0.5 ml dosage	54	54	$21
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	126	139	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	23	1,290	$24,778
Xarelto	Rivaroxaban	14	1,020	$18,222
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	20	441	$4,138
Levothyroxine Sodium	Levothyroxine Sodium	51	4,170	$2,020
Atorvastatin Calcium	Atorvastatin Calcium	170	14,758	$1,825

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$122	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Paul M. Katz, DO?

Tedicare shows public-source Medicare data for Paul M. Katz, DO (NPI 1629047154), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul M. Katz, DO have ACO affiliation data?

Paul M. Katz, DO is shown with ACO affiliation data for Netrin Primary Care ACO, LLC (MSSP, ACO ID A3272).

What billing organization is linked to Paul M. Katz, DO?

Paul M. Katz, DO is linked to CHESAPEAKE WELLNESS CENTER (billing NPI 1083163307) in the available physician profile data.

Does Paul M. Katz, DO have Open Payments data?

Paul M. Katz, DO has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.